Indication

Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.

Medicine details

Medicine name:
follitropin delta (Rekovelle)
SMC ID:
SMC2670
Pharmaceutical company
Ferring Pharmaceuticals Ltd
Submission type
Abbreviated
Publication due date:
08 July 2024